Non-Invasive Measurement of Drug and 2-HG Signals Using 19F and 1H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032.
Katharina J WengerChristian RichterMichael C BurgerHans UrbanStefan KaulfussPatrick N HarterSridhar SreeramuluHarald SchwalbeJoachim P SteinbachElke HattingenOliver BährUlrich PilatusPublished in: Cancers (2020)
Non-invasive monitoring of mIDH1 inhibition by BAY1436032 in mIDH1 gliomas is feasible.